BOLD
Price
$1.43
Change
+$0.03 (+2.14%)
Updated
Jun 18 closing price
Capitalization
32.12M
59 days until earnings call
Intraday BUY SELL Signals
RXRX
Price
$3.23
Change
+$0.12 (+3.86%)
Updated
Jun 18 closing price
Capitalization
1.71B
53 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BOLD vs RXRX

BOLD vs RXRX Comparison Chart in %
View a ticker or compare two or three
VS
BOLD vs. RXRX commentary
Jun 19, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BOLD is a Hold and RXRX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 19, 2026
Stock price -- (BOLD: $1.40 vs. RXRX: $3.11)
Brand notoriety: BOLD and RXRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BOLD: 25% vs. RXRX: 133%
Market capitalization -- BOLD: $32.12M vs. RXRX: $1.71B
BOLD [@Biotechnology] is valued at $32.12M. RXRX’s [@Biotechnology] market capitalization is $1.71B. The market cap for tickers in the [@Biotechnology] industry ranges from $114.63B to $0. The average market capitalization across the [@Biotechnology] industry is $1.95B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BOLD’s FA Score shows that 1 FA rating(s) are green whileRXRX’s FA Score has 1 green FA rating(s).

  • BOLD’s FA Score: 1 green, 4 red.
  • RXRX’s FA Score: 1 green, 4 red.
According to our system of comparison, BOLD is a better buy in the long-term than RXRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BOLD’s TA Score shows that 3 TA indicator(s) are bullish while RXRX’s TA Score has 2 bullish TA indicator(s).

  • BOLD’s TA Score: 3 bullish, 5 bearish.
  • RXRX’s TA Score: 2 bullish, 8 bearish.
According to our system of comparison, BOLD is a better buy in the short-term than RXRX.

Price Growth

BOLD (@Biotechnology) experienced а +1.45% price change this week, while RXRX (@Biotechnology) price change was +2.30% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.61%. For the same industry, the average monthly price growth was +8.78%, and the average quarterly price growth was +2225.89%.

Reported Earning Dates

BOLD is expected to report earnings on Aug 17, 2026.

RXRX is expected to report earnings on Aug 11, 2026.

Industries' Descriptions

@Biotechnology (+2.61% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RXRX($1.71B) has a higher market cap than BOLD($32.1M). BOLD YTD gains are higher at: 16.667 vs. RXRX (-23.961). BOLD has higher annual earnings (EBITDA): -59.47M vs. RXRX (-478.66M). RXRX has more cash in the bank: 654M vs. BOLD (92.8M). BOLD has less debt than RXRX: BOLD (48.3M) vs RXRX (72.4M). RXRX has higher revenues than BOLD: RXRX (65.7M) vs BOLD (0).
BOLDRXRXBOLD / RXRX
Capitalization32.1M1.71B2%
EBITDA-59.47M-478.66M12%
Gain YTD16.667-23.961-70%
P/E Ratio0.16N/A-
Revenue065.7M-
Total Cash92.8M654M14%
Total Debt48.3M72.4M67%
TECHNICAL ANALYSIS
Technical Analysis
BOLDRXRX
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
71%
Bullish Trend 1 day ago
81%
Momentum
ODDS (%)
Bearish Trend 1 day ago
74%
Bearish Trend 1 day ago
89%
MACD
ODDS (%)
N/A
Bearish Trend 1 day ago
88%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
82%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
73%
Bullish Trend 1 day ago
81%
Advances
ODDS (%)
Bullish Trend 8 days ago
84%
Bullish Trend 8 days ago
83%
Declines
ODDS (%)
Bearish Trend 10 days ago
90%
Bearish Trend 3 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
BOLD
Daily Signal:
Gain/Loss:
RXRX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BOSC4.320.05
+1.17%
B.O.S. Better Online Solutions
OVLY33.64-0.09
-0.27%
Oak Valley Bancorp (CA)
TJX164.13-2.19
-1.32%
TJX Companies
FNB18.10-0.28
-1.52%
FNB Corp
WWW16.70-1.04
-5.86%
Wolverine World Wide

BOLD and

Correlation & Price change

A.I.dvisor indicates that over the last year, BOLD has been loosely correlated with TVTX. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if BOLD jumps, then TVTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BOLD
1D Price
Change %
BOLD100%
-0.71%
TVTX - BOLD
37%
Loosely correlated
+1.42%
ACET - BOLD
36%
Loosely correlated
+4.38%
DNA - BOLD
32%
Poorly correlated
+4.14%
RXRX - BOLD
31%
Poorly correlated
-2.20%
CRBU - BOLD
31%
Poorly correlated
-2.96%
More